Home
CHRS
CHRS News

Latest Coherus BioSciences Inc. (CHRS) News on July 26, 2024

MT Newswires

24 days ago

Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada

MT Newswires

25 days ago

Baird Trims Price Target on Coherus BioSciences to $8 From $9, Maintains Outperform Rating

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar

BioPharma Dive

a month ago

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar

MT Newswires

a month ago

Coherus BioSciences to Sell Yusimry to Hong Kong King-Friend Industrial in $40 Million Cash Transaction

Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction

GlobeNewswire

a month ago

Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

GlobeNewswire

2 months ago

Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

2 months ago

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA

GlobeNewswire

2 months ago

Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA

We Think Some Shareholders May Hesitate To Increase Coherus BioSciences, Inc.'s (NASDAQ:CHRS) CEO Compensation

Simply Wall St.

2 months ago

We Think Some Shareholders May Hesitate To Increase Coherus BioSciences, Inc.'s (NASDAQ:CHRS) CEO Compensation

MT Newswires

2 months ago

Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating

Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

3 months ago

Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript

Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates

Zacks

3 months ago

Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates

Associated Press Finance

3 months ago

Coherus BioSciences: Q1 Earnings Snapshot

Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update

Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire

3 months ago

Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?

Simply Wall St.

3 months ago

When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?

Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer

GlobeNewswire

3 months ago

Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024

GlobeNewswire

3 months ago

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

3 months ago

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years

Simply Wall St.

4 months ago

Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

GlobeNewswire

4 months ago

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript

Coherus BioSciences Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

4 months ago

Coherus BioSciences Full Year 2023 Earnings: EPS Misses Expectations

Why Coherus Biosciences Stock Tumbled on Thursday

Motley Fool

4 months ago

Why Coherus Biosciences Stock Tumbled on Thursday

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Coherus BioSciences Inc Earnings Call

Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...

GuruFocus.com

4 months ago

Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...

Associated Press Finance

4 months ago

Coherus BioSciences: Q4 Earnings Snapshot

Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update

GlobeNewswire

4 months ago

Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update

In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions

Simply Wall St.

5 months ago

In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions

Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

GlobeNewswire

5 months ago

Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

Coherus Completes Divestiture of Ophthalmology Franchise

GlobeNewswire

5 months ago

Coherus Completes Divestiture of Ophthalmology Franchise

Coherus BioSciences Announces New Employment Inducement Grants

GlobeNewswire

5 months ago

Coherus BioSciences Announces New Employment Inducement Grants

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

GlobeNewswire

5 months ago

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Why Coherus BioSciences Stock Jumped Today

Motley Fool

6 months ago

Why Coherus BioSciences Stock Jumped Today

Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP

GlobeNewswire

6 months ago

Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP

Coach says Japan must improve in 'many aspects' after Asian Cup exit

AFP

6 months ago

Coach says Japan must improve in 'many aspects' after Asian Cup exit

WaFd (WAFD)-Luther Burbank (LBC) Merger Gets Regulatory Nod

Zacks

6 months ago

WaFd (WAFD)-Luther Burbank (LBC) Merger Gets Regulatory Nod

Invesco Closed-End Funds Declare Dividends

PR Newswire

6 months ago

Invesco Closed-End Funds Declare Dividends

When Can We Expect A Profit From Youdao, Inc. (NYSE:DAO)?

Simply Wall St.

6 months ago

When Can We Expect A Profit From Youdao, Inc. (NYSE:DAO)?

First Community Bankshares (NASDAQ:FCBC) Is Due To Pay A Dividend Of $0.29

Simply Wall St.

6 months ago

First Community Bankshares (NASDAQ:FCBC) Is Due To Pay A Dividend Of $0.29

Univest Financial Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

6 months ago

Univest Financial Full Year 2023 Earnings: EPS Beats Expectations

Peapack-Gladstone (PGC) Misses Q4 Earnings and Revenue Estimates

Zacks

6 months ago

Peapack-Gladstone (PGC) Misses Q4 Earnings and Revenue Estimates

ACNB Corp (ACNB) Reports Decline in Q4 Net Income Amid Investment Portfolio Repositioning

GuruFocus.com

6 months ago

ACNB Corp (ACNB) Reports Decline in Q4 Net Income Amid Investment Portfolio Repositioning

Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be

Simply Wall St.

6 months ago

Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be

Atrion (NASDAQ:ATRI) investors are sitting on a loss of 54% if they invested five years ago

Simply Wall St.

6 months ago

Atrion (NASDAQ:ATRI) investors are sitting on a loss of 54% if they invested five years ago

Why Coherus BioSciences Stock Is Sinking Today

Motley Fool

6 months ago

Why Coherus BioSciences Stock Is Sinking Today

Why Coherus Biosciences Popped Today

Motley Fool

6 months ago

Why Coherus Biosciences Popped Today

CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

6 months ago

CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal

GlobeNewswire

6 months ago

Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal

Is First Business Financial Services (FBIZ) Stock Undervalued Right Now?

Zacks

6 months ago

Is First Business Financial Services (FBIZ) Stock Undervalued Right Now?

Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium

GlobeNewswire

6 months ago

Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium

Applied Digital Reports Fiscal Second Quarter 2024 Results

GlobeNewswire

6 months ago

Applied Digital Reports Fiscal Second Quarter 2024 Results

Houthis Turn Their Sights on U.S. Ships, Vow to Keep Attacking Red Sea Targets

The Wall Street Journal

6 months ago

Houthis Turn Their Sights on U.S. Ships, Vow to Keep Attacking Red Sea Targets

Invesco Municipal Trust's Dividend Analysis

GuruFocus.com

6 months ago

Invesco Municipal Trust's Dividend Analysis

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

Insider Monkey

6 months ago

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

Gatos Silver Reports 2023 Silver Production Near Top End of Guidance

GlobeNewswire

7 months ago

Gatos Silver Reports 2023 Silver Production Near Top End of Guidance

Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference

Guaranty Bancshares, Inc. Announces Fourth Quarter and Year-End 2023 Earnings Release and Conference Call Schedule

Business Wire

7 months ago

Guaranty Bancshares, Inc. Announces Fourth Quarter and Year-End 2023 Earnings Release and Conference Call Schedule

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

PR Newswire

7 months ago

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

Maui Land & Pineapple Company appoints new board members to support next chapter of growth

GlobeNewswire

7 months ago

Maui Land & Pineapple Company appoints new board members to support next chapter of growth

Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Melt Pharmaceuticals Provides Corporate Update

Business Wire

7 months ago

Melt Pharmaceuticals Provides Corporate Update

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) is definitely on the radar of institutional investors who own 40% of the company

Simply Wall St.

7 months ago

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) is definitely on the radar of institutional investors who own 40% of the company

Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody

Zacks

7 months ago

Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody

Reuters

7 months ago

Dazheng Group consortium announces bid to buy Hollysys Automation for $1.8 billion

Reuters

7 months ago

Dazheng Group consortium announces bid to buy Hollysys Automation at $1.8 bln

Donegal Group Inc. Announces Quarterly Dividend

GlobeNewswire

7 months ago

Donegal Group Inc. Announces Quarterly Dividend

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference

PR Newswire

7 months ago

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference

Northeast Bank (NASDAQ:NBN) is favoured by institutional owners who hold 60% of the company

Simply Wall St.

7 months ago

Northeast Bank (NASDAQ:NBN) is favoured by institutional owners who hold 60% of the company

Investing.com

7 months ago

Macy's shares jump 20% on $5.8 billion buyout offer: 4 big deal reports

Red River Bancshares, Inc. Announces Renewal of Stock Repurchase Program

GlobeNewswire

7 months ago

Red River Bancshares, Inc. Announces Renewal of Stock Repurchase Program

10 Very Cheap Energy Stocks Ready To Explode

Insider Monkey

7 months ago

10 Very Cheap Energy Stocks Ready To Explode

3D Systems Announces Organization Changes and New Executive Leadership Appointments

GlobeNewswire

7 months ago

3D Systems Announces Organization Changes and New Executive Leadership Appointments

Why Clean Energy Fuels Stock Popped Today

Motley Fool

7 months ago

Why Clean Energy Fuels Stock Popped Today

How Much Upside is Left in Castle Biosciences, Inc. (CSTL)? Wall Street Analysts Think 67.01%

Zacks

7 months ago

How Much Upside is Left in Castle Biosciences, Inc. (CSTL)? Wall Street Analysts Think 67.01%

12 Best Genomics Stocks To Buy Now

Insider Monkey

8 months ago

12 Best Genomics Stocks To Buy Now

Univest Financial Corporation (NASDAQ:UVSP) is favoured by institutional owners who hold 74% of the company

Simply Wall St.

8 months ago

Univest Financial Corporation (NASDAQ:UVSP) is favoured by institutional owners who hold 74% of the company

PR Newswire

8 months ago

UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE

Interface Elects Catherine Marcus to Board of Directors

Business Wire

8 months ago

Interface Elects Catherine Marcus to Board of Directors

Lufthansa Group and Lilium sign Memorandum of Understanding for strategic partnership

GlobeNewswire

8 months ago

Lufthansa Group and Lilium sign Memorandum of Understanding for strategic partnership

Business Wire

8 months ago

Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Remembering Charlie Munger

GuruFocus.com

8 months ago

Remembering Charlie Munger

Southwest Gas, SP Plus, and More Stocks See Action From Activist Investors

Barrons.com

8 months ago

Southwest Gas, SP Plus, and More Stocks See Action From Activist Investors

Star Group, L.P. to Host Fiscal 2023 Fourth Quarter Webcast and Conference Call December 7, 2023

GlobeNewswire

8 months ago

Star Group, L.P. to Host Fiscal 2023 Fourth Quarter Webcast and Conference Call December 7, 2023

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Business Wire

8 months ago

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

/C O R R E C T I O N -- Ituran Location and Control Ltd./

PR Newswire

8 months ago

/C O R R E C T I O N -- Ituran Location and Control Ltd./

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2023 Earnings Call Transcript

Alta Equipment Group Announces Common Stock Dividend

GlobeNewswire

9 months ago

Alta Equipment Group Announces Common Stock Dividend

Share on Social Networks: